Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 139
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05148572 | Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma | ||
| NCT01394315 | Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer | ||
| NCT01716689 | Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas | ||
| NCT02548039 | To Study The Influence Of Genomic Factors On Metabolism And Effects Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients. | ||
| NCT00589238 | Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery | ||
| NCT03200730 | A Novel Family Dignity Intervention (FDI) for Asian Palliative Care | ||
| NCT04451603 | LiverMultiScan Analysis of MRI Scans in HCC | ||
| NCT04118114 | Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors | ||
| NCT06956248 | Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE) | ||
| NCT02368860 | OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma | ||
| NCT04660188 | Impact of a Breast cAncer Survivorship Interprofessional Community Care Model | ||
| NCT02944708 | Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma | ||
| NCT04087473 | Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC | ||
| NCT01022723 | Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells | ||
| NCT02435927 | ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin | ||
| NCT04965259 | Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE) | ||
| NCT00486213 | Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer | ||
| NCT06294808 | Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC | ||
| NCT00003637 | Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx | ||
| NCT04224480 | Longitudinal Immune-phenotyping of HCC Following MK-3475 | ||
| NCT04664829 | The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC | ||
| NCT02806388 | Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project | ||
| NCT06093061 | Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma | ||
| NCT04632173 | Head and Neck cancERs International cOviD-19 collabOraTion | ||
| NCT05286437 | Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole | ||
| NCT04961489 | Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes | ||
| NCT04072107 | EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR) | ||
| NCT06244953 | Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care | ||
| NCT04946968 | Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers | ||
| NCT06418412 | A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC | ||
| NCT04912765 | Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC | ||
| NCT03430128 | Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC | ||
| NCT04986748 | Using QPOP to Predict Treatment for Sarcomas and Melanomas | ||
| NCT02931864 | Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors | ||
| NCT03091491 | Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer | ||
| NCT03984578 | Window of Opportunity Study in Colorectal Cancer | ||
| NCT00690872 | Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer | ||
| NCT02143388 | Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial | ||
| NCT04448522 | Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma | ||
| NCT00702182 | Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer | ||
| NCT04956068 | PIPAC for Peritoneal Metastases | ||
| NCT01135056 | Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC) | ||
| NCT01736410 | A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | ||
| NCT01765686 | Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery | ||
| NCT00997906 | Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC | ||
| NCT05355558 | A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer | ||
| NCT02808091 | Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma | ||
| NCT03515174 | Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO | ||
| NCT03325218 | Survival Expectations and Hope Among Cancer Patients at End-of-Life | ||
| NCT02804776 | PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery |
